1. Home
  2. BTGO vs AMPH Comparison

BTGO vs AMPH Comparison

Compare BTGO & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTGO

BitGo Holdings Inc. Class A Common Stock

N/A

Current Price

$8.19

Market Cap

961.8M

Sector

Finance

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$17.16

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTGO
AMPH
Founded
2013
1996
Country
United States
United States
Employees
603
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
961.8M
971.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
BTGO
AMPH
Price
$8.19
$17.16
Analyst Decision
Strong Buy
Buy
Analyst Count
9
8
Target Price
$14.83
$28.38
AVG Volume (30 Days)
654.5K
568.2K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
$34.41
$4.64
P/E Ratio
$10.81
$120.25
Revenue Growth
N/A
N/A
52 Week Low
$7.25
$16.76
52 Week High
$15.30
$31.26

Technical Indicators

Market Signals
Indicator
BTGO
AMPH
Relative Strength Index (RSI) 35.70 33.88
Support Level $7.25 $17.03
Resistance Level $12.40 $24.16
Average True Range (ATR) 0.89 0.86
MACD -0.35 -0.60
Stochastic Oscillator 4.01 7.21

Price Performance

Historical Comparison
BTGO
AMPH

About BTGO BitGo Holdings Inc. Class A Common Stock

BitGo Holdings Inc provides various offerings to its clients including multi-signature blockchain wallet solutions allowing for secure storage, trade settlement, staking solutions, and lending of digital assets. The Company also provides professional services to develop smart contracts. Its clients range from crypto-native companies that use its self-custody wallet technology to traditional financial services firms that leverage its licensed custody, staking and trading capabilities within their own products and services.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: